Pivotal topline data from the phase 1/2 TRIDENT-1 trial of repotrectinib in patients with ROS1+ advanced non-small cell lung cancer (NSCLC)

B. C. Cho; J. Lin; D. R. Camidge; V. Velcheti; B. Solomon; S. Lu; K. H. Lee; S. W. Kim; S. Kao; R. Diadziuskzko; M. Beg; M. Nagasaka; E. Felip; B. Besse; C. Springfeld; S. Popat; J. Wolf; D. Trone; S. Stopatschinskaja; A. Drilon

doi:10.1016/S0959-8049(22)00812-7

Pivotal topline data from the phase 1/2 TRIDENT-1 trial of repotrectinib in patients with ROS1+ advanced non-small cell lung cancer (NSCLC)

B. C. Cho, J. Lin, D. R. Camidge, V. Velcheti, B. Solomon, S. Lu, K. H. Lee, S. W. Kim, S. Kao, R. Diadziuskzko, M. Beg, M. Nagasaka, E. Felip, B. Besse, C. Springfeld, S. Popat, J. Wolf, D. Trone, S. Stopatschinskaja, A. Drilon

Department of Internal Medicine

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	S1-S2
Journal	European Journal of Cancer
Volume	174
DOIs	https://doi.org/10.1016/S0959-8049(22)00812-7
Publication status	Published - 2022 Oct

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S0959-8049(22)00812-7

Cite this

Cho, B. C., Lin, J., Camidge, D. R., Velcheti, V., Solomon, B., Lu, S., Lee, K. H., Kim, S. W., Kao, S., Diadziuskzko, R., Beg, M., Nagasaka, M., Felip, E., Besse, B., Springfeld, C., Popat, S., Wolf, J., Trone, D., Stopatschinskaja, S., & Drilon, A. (2022). Pivotal topline data from the phase 1/2 TRIDENT-1 trial of repotrectinib in patients with ROS1+ advanced non-small cell lung cancer (NSCLC). European Journal of Cancer, 174, S1-S2. https://doi.org/10.1016/S0959-8049(22)00812-7

@article{c7f8cdc6a60e4dd688cae5462fc9ab4e,

title = "Pivotal topline data from the phase 1/2 TRIDENT-1 trial of repotrectinib in patients with ROS1+ advanced non-small cell lung cancer (NSCLC)",

author = "Cho, {B. C.} and J. Lin and Camidge, {D. R.} and V. Velcheti and B. Solomon and S. Lu and Lee, {K. H.} and Kim, {S. W.} and S. Kao and R. Diadziuskzko and M. Beg and M. Nagasaka and E. Felip and B. Besse and C. Springfeld and S. Popat and J. Wolf and D. Trone and S. Stopatschinskaja and A. Drilon",

year = "2022",

month = oct,

doi = "10.1016/S0959-8049(22)00812-7",

language = "English",

volume = "174",

pages = "S1--S2",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Limited",

}

Cho, BC, Lin, J, Camidge, DR, Velcheti, V, Solomon, B, Lu, S, Lee, KH, Kim, SW, Kao, S, Diadziuskzko, R, Beg, M, Nagasaka, M, Felip, E, Besse, B, Springfeld, C, Popat, S, Wolf, J, Trone, D, Stopatschinskaja, S & Drilon, A 2022, 'Pivotal topline data from the phase 1/2 TRIDENT-1 trial of repotrectinib in patients with ROS1+ advanced non-small cell lung cancer (NSCLC)', European Journal of Cancer, vol. 174, pp. S1-S2. https://doi.org/10.1016/S0959-8049(22)00812-7

TY - JOUR

T1 - Pivotal topline data from the phase 1/2 TRIDENT-1 trial of repotrectinib in patients with ROS1+ advanced non-small cell lung cancer (NSCLC)

AU - Cho, B. C.

AU - Lin, J.

AU - Camidge, D. R.

AU - Velcheti, V.

AU - Solomon, B.

AU - Lu, S.

AU - Lee, K. H.

AU - Kim, S. W.

AU - Kao, S.

AU - Diadziuskzko, R.

AU - Beg, M.

AU - Nagasaka, M.

AU - Felip, E.

AU - Besse, B.

AU - Springfeld, C.

AU - Popat, S.

AU - Wolf, J.

AU - Trone, D.

AU - Stopatschinskaja, S.

AU - Drilon, A.

PY - 2022/10

Y1 - 2022/10

UR - http://www.scopus.com/inward/record.url?scp=85140460065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85140460065&partnerID=8YFLogxK

U2 - 10.1016/S0959-8049(22)00812-7

DO - 10.1016/S0959-8049(22)00812-7

M3 - Article

AN - SCOPUS:85140460065

SN - 0959-8049

VL - 174

SP - S1-S2

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Pivotal topline data from the phase 1/2 TRIDENT-1 trial of repotrectinib in patients with ROS1+ advanced non-small cell lung cancer (NSCLC)

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Cite this